Depression in Visual Impairment Trial (DEPVIT)
The National Institute for Health and Clinical Excellence (NICE) recommends screening high risk groups for depression and providing treatment according to the ‘stepped care’ framework. However, although there are good reasons for believing that the prevalence of depression is high in people who access low vision rehabilitation services, screening and referral for treatment is not currently part of the service.
Therefore, this study aims to establish depression screening and referral for treatment in 2 centres to a) estimate the prevalence of depressive symptoms in consecutive attendees of low vision services in England and Wales, and b) to compare 3 interventions for newly-diagnosed low vision patients with depressive symptoms in an exploratory randomised controlled trial.
We also aim to obtain preliminary information about the cost effectiveness of our interventions. The study is supported by the charity Guide Dogs and will start recruitment in September 2011. Outcomes should be available in April 2014 To learn more about DEPVIT meet the research team, view the documents (right hand side) or contact the Study Co-ordinator for more information.